Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis

Two phase-III, double-blind, randomized clinical trials of remdesivir plus SOC (standard of care) versus placebo plus SOC have been conducted in Wuhan hospitals by Chinese investigators during the urgent COVID-19 epidemic [ClincalTrials.gov NCT04257656 and NCT04252664]. These trials have been highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Weichung J., Yao, Chen, Xie, Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229886/
https://www.ncbi.nlm.nih.gov/pubmed/32865809
http://dx.doi.org/10.1007/s43441-020-00159-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229886/
https://www.ncbi.nlm.nih.gov/pubmed/32865809
http://dx.doi.org/10.1007/s43441-020-00159-7

Ejemplares similares